The Board of Directors of Duopharma Biotech Berhad ("Duopharma Biotech" or the "Company”) wishes to announce that the ordinary resolution as set out in the Notice of the Meeting of Members ("MOM") dated 6 July 2021 has been passed by the shareholders of Duopharma Biotech at the MOM held today.
The voting in respect of the resolution wascarried out by way of poll and the result wasvalidated by Scrutineer Solutions Sdn. Bhd., the independent scrutineer appointed by Duopharma Biotech.
Please refer to the attachment for the resultof the poll as validated by the independent scrutineer.
This announcement is dated 13 August 2021.
Voting Results |
||
1. ORDINARY RESOLUTION |
||
Description |
PROPOSED BONUS ISSUE OF 235,443,397 NEW ORDINARY SHARES IN DUOPHARMA BIOTECH BERHAD ("DUOPHARMA SHARES") ("BONUS SHARES") ON THE BASIS OF 1 BONUS SHARE FOR EVERY 3 EXISTING DUOPHARMA SHARES HELD ON AN ENTITLEMENT DATE TO BE DETERMINED AND ANNOUNCED LATER |
|
Shareholder’s Action | For Voting | |
Voted | For | Against |
No. of Shareholders | 568 | 49 |
No. of Shares | 480,905,928 | 41,786 |
% of Voted Shares | 99.9913 | 0.0087 |
Result | Accepted | |